U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07745998) titled 'The BRIGHT Study (Device Name: HALO System)' on July 03.
Brief Summary: The purpose of the BRIGHT study is to evaluate safety and performance of the HALO SYSTEM in subjects with diabetes mellitus. The primary objectives of this clinical investigation are 1) the evaluation of sensor's performance by demonstrating sensor's accuracy and stability and 2) to confirm safe implantation of the Sensor and safety of the device during implantation.
Study Start Date: Dec., 2026
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus - Type 1
Diabetes Mellitus - Type 2
Diabetes Mellitus
Ketoacidosis, Diabetic
Hyperglycaemia (Diabetic)
Hypogly...